Variant report
Variant | nsv558703 |
---|---|
Chromosome Location | chr12:43015532-43025256 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:22)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:22 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CHD2 | chr12:43019491-43019597 | K562 | blood: | n/a | n/a |
2 | CTCF | chr12:43016180-43016330 | NB4 | blood: | n/a | n/a |
3 | EP300 | chr12:43024204-43024416 | K562 | blood: | n/a | n/a |
4 | KAP1 | chr12:43023782-43024522 | U2OS | brain: | n/a | n/a |
5 | KAP1 | chr12:43023607-43024511 | HEK293 | kidney: | n/a | n/a |
6 | MXI1 | chr12:43018683-43018684 | HepG2 | liver: | n/a | n/a |
7 | NFIC | chr12:43019321-43019865 | ECC-1 | luminal epithelium: | n/a | n/a |
8 | NFYA | chr12:43019379-43019678 | K562 | blood: | n/a | chr12:43019530-43019548 chr12:43019554-43019572 |
9 | NFYA | chr12:43019481-43019684 | Hela-S3 | cervix: | n/a | chr12:43019530-43019548 chr12:43019554-43019572 |
10 | NFYB | chr12:43019303-43019703 | K562 | blood: | n/a | chr12:43019560-43019575 chr12:43019536-43019551 chr12:43019512-43019527 |
11 | NFYB | chr12:43019379-43019617 | GM12878 | blood: | n/a | chr12:43019560-43019575 chr12:43019536-43019551 chr12:43019512-43019527 |
12 | NFYB | chr12:43019394-43019613 | Hela-S3 | cervix: | n/a | chr12:43019560-43019575 chr12:43019536-43019551 chr12:43019512-43019527 |
13 | POLR2A | chr12:43018918-43019033 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr12:43023607-43023620 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | POLR2A | chr12:43023525-43023576 | GM12878 | blood: | n/a | n/a |
16 | POLR2A | chr12:43019211-43019398 | GM12878 | blood: | n/a | n/a |
17 | RCOR1 | chr12:43024116-43024461 | K562 | blood: | n/a | n/a |
18 | SETDB1 | chr12:43023947-43024926 | U2OS | brain: | n/a | n/a |
19 | TAL1 | chr12:43024297-43024443 | K562 | blood: | n/a | n/a |
20 | TCF7L2 | chr12:43023886-43024538 | HEK293 | kidney: | n/a | n/a |
21 | TEAD4 | chr12:43024071-43024481 | K562 | blood: | n/a | n/a |
22 | ZNF384 | chr12:43024570-43024588 | K562 | blood: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:43014304..43016802-chr12:43019715..43022401,2 | MCF-7 | breast: | |
2 | chr12:43018191..43020196-chr12:43021950..43023568,2 | K562 | blood: | |
3 | chr12:43018191..43020196-chr12:43021950..43023568,2 | K562 | blood: | |
4 | chr12:43020347..43023127-chr12:43029388..43031746,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PRICKLE1-1 | chr12:43023263-43023488 | ENSG00000257510 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000257687 | TF binding region |
ENSG00000257405 | chromatin interactions |
ENSG00000257687 | chromatin interactions |
POGZ | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12308577 | chr12:43015532-43015533 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs115965432 | chr12:43015544-43015545 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs535043943 | chr12:43015573-43015574 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs118178290 | chr12:43015582-43015583 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs141903360 | chr12:43015583-43015584 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs568929507 | chr12:43015599-43015600 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs150632038 | chr12:43015628-43015629 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs561799102 | chr12:43015638-43015639 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs192351656 | chr12:43015705-43015706 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs547590709 | chr12:43015728-43015729 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs74340883 | chr12:43015770-43015771 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs140929072 | chr12:43015794-43015795 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs57557308 | chr12:43015795-43015796 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs184941948 | chr12:43015797-43015798 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs77599095 | chr12:43015799-43015800 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs7133172 | chr12:43015863-43015864 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs147928842 | chr12:43015924-43015925 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs140233654 | chr12:43015926-43015927 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs554350181 | chr12:43015948-43015949 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs7307159 | chr12:43015964-43015965 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs555651018 | chr12:43015992-43015993 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs540131977 | chr12:43016037-43016038 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs558515553 | chr12:43016072-43016073 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs150057045 | chr12:43016114-43016115 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs2204906 | chr12:43016128-43016129 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs145474476 | chr12:43016131-43016132 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs75334863 | chr12:43016195-43016196 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs572446880 | chr12:43016213-43016214 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs540827535 | chr12:43016221-43016222 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs374619450 | chr12:43016313-43016314 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs559489877 | chr12:43016337-43016338 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs7133774 | chr12:43016361-43016362 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs544882344 | chr12:43016364-43016365 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs148817255 | chr12:43016370-43016371 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs7133039 | chr12:43016395-43016396 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs143507711 | chr12:43016420-43016421 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs531021228 | chr12:43016421-43016422 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs76090554 | chr12:43016450-43016451 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs547618877 | chr12:43016453-43016454 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs564628109 | chr12:43016463-43016464 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs566239553 | chr12:43016479-43016480 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs540071601 | chr12:43016515-43016516 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs7955064 | chr12:43016527-43016528 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs570383758 | chr12:43016540-43016541 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs146442737 | chr12:43016544-43016545 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs188932598 | chr12:43016584-43016585 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs562022958 | chr12:43016585-43016586 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs141013370 | chr12:43016586-43016587 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs541119090 | chr12:43016587-43016588 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs182061973 | chr12:43016594-43016595 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:43006000-43015800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr12:43008200-43016200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr12:43015800-43016400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr12:43016000-43016400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr12:43016000-43016400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr12:43016000-43016600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr12:43016200-43017000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr12:43017000-43020800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr12:43018200-43019200 | Enhancers | Primary monocytes fromperipheralblood | blood |
10 | chr12:43018400-43019200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
11 | chr12:43020800-43021000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr12:43020800-43021200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr12:43021000-43021800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr12:43021400-43022000 | Enhancers | Fetal Stomach | stomach |
15 | chr12:43024400-43026200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
16 | chr12:43024800-43026000 | Enhancers | Primary monocytes fromperipheralblood | blood |
17 | chr12:43025000-43026000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
18 | chr12:43025200-43025600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
19 | chr12:43025200-43026000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
20 | chr12:43025200-43026600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |